EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation

By Davidson A.   Dick G.   Pritchard-Jones K.   Pinkerton R.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2422-2427

Elsevier

Access to resources Recommend Favorite

A Prospective Randomised Study in Limited Disease Small Cell Carcinoma--Doxorubicin and Vincristine plus Either Cyclophosphamide or Etoposide

By Abratt R.P.   Salton D.G.M.   Malan J.R.   Willcox P.A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1637-1639

Elsevier

Access to resources Recommend Favorite

Response of Previously Untreated Metastatic Rhabdomyosarcoma to Combination Chemotherapy with Carboplatin, Epirubicin and Vincristine

By on behalf of the MMT Working Party of the International Society of Paediatric Oncologists   Frascella E.   Pritchard-Jones K.   Modak S.   Mancini A.F.   Carli M.   Pinkerton C.R.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 821-825

Elsevier

Access to resources Recommend Favorite

Epirubicin and Etoposide Combination Chemotherapy to Treat Hepatocellular Carcinoma Patients: a Phase II Study

By Bobbio-Pallavicini E.   Porta C.   Moroni M.   Bertulezzi G.   Civelli L.   Pugliese P.   Nastasi G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1784-1788

Elsevier

Access to resources Recommend Favorite

A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix

By Tabata Tsutomu   Nishiura Keisuke   Yanoh Kenji   Okugawa Toshiharu   Obata Hidenori   Tanaka Keisuke   Toyoda Nagayasu  

International Journal of Clinical Oncology, Vol. 9, Iss. 1, 2004-02 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite